Linda E Kelemen
5PUBLICATIONS
188CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.Flurina A M Saner, Kazuaki Takahashi, Timothy Budden
|Oct 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield
|Jun 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Aline Talhouk, Joshy George, Chen Wang
|Apr 14, 2019
Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma.Dylan Z Dieters-Castator, Peter F Rambau, Linda E Kelemen
|Aug 24, 2018
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.Linda E Kelemen, Madalene Earp, Brooke L Fridley
Pageof 1
Frequent Collaborators
4 joint publications
Susan J Ramus
4 joint publications
Martin Köbel
4 joint publications
Paul D P Pharoah
3 joint publications
Holly R Harris
3 joint publications
Usha Menon
3 joint publications
Aline Talhouk
3 joint publications
Jennifer M Koziak
3 joint publications
Catherine J Kennedy
3 joint publications
Jacek Gronwald
3 joint publications
James D Brenton
